Autoinjectors Market

Global Autoinjectors Market Report: By Route of Administration (Intramuscular, Subcutaneous), By End-User (Hospitals & Clinics, Home Care Settings, Ambulatory Care Settings), Therapy (Anaphylaxis, Diabetes, Multiple Sclerosis, Rheumatoid Arthritis, Other Therapies), By Type (Reusable Autoinjectors, Disposable Autoinjectors), and Region (North America, Europe, Asia-Pacific, Latin America, Middle-East and Africa) Global Industry Analysis, Size, Share, Growth, Trends, Regional Analysis, Competitor Analysis and Forecast 2023-2031.

Medical Devices | January 2024 | Report ID: EMR00428 | Pages: 301

Global Autoinjectors market is predicted to reach approximately USD 21.77 billion by 2031, at a CAGR of 9.75% from 2022 to 2031.

Autoinjectors are medical devices designed for the automatic injection of a pre-measured dose of a drug. Because of their intuitive design, which makes it possible for patients to take their medications at home and lessens the need for frequent hospital visits, they have become well-known. The market covers a broad spectrum of therapeutic areas, some of which are diabetes, rheumatoid arthritis, multiple sclerosis, and anaphylaxis.

The ageing population and the resulting rise in the prevalence of chronic diseases are two major factors driving the autoinjector market. More and more patients are choosing to self-administer their medications in order to save money on healthcare and increase convenience. The market's growth has also been significantly influenced by technological developments, with breakthroughs like electronic autoinjectors providing increased accuracy and user-friendliness. Furthermore, autoinjector adoption has accelerated globally due to growing awareness of the advantages of early disease management and the significance of timely medication administration.

 

 

Global Autoinjectors report scope and segmentation.

Report Attribute

Details

Estimated Market Value (2022)

USD 9.42 billion

Projected Market Value (2031)

USD 21.77 billion

Base Year

2022

Forecast Years

2023 – 2031

Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Based on By Route of Administration, Type, Therapy, End-User & Region.

Segments Covered

By Route of Administration, Type, Therapy, End-User & By Region.

Forecast Units

Value (USD Billion or Million), and Volume (Units)

Quantitative Units

Revenue in USD million/billion and CAGR from 2023 to 2031.

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others.

Report Coverage

Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis.

Delivery Format

Delivered as an attached PDF and Excel through email, according to the purchase option.

 

Global Autoinjectors dynamics

An increase in diseases like rheumatoid arthritis, diabetes, and multiple sclerosis has been caused by an ageing population and changes in lifestyle, which has increased demand for convenient and effective drug delivery devices like autoinjectors. The market is being driven by the increasing inclination towards self-administration of medications, which is fuelled by the desire to reduce healthcare costs and improve patient autonomy. Innovations such as electronic autoinjectors and connected devices, which provide better accuracy, user-friendliness, and real-time data monitoring, are crucial.

 

Global Autoinjectors drivers

  • Rising Incidence of Chronic Diseases

Globally, the increasing prevalence of chronic illnesses is one of the main factors driving the autoinjector market. The prevalence of diseases like multiple sclerosis, diabetes, and rheumatoid arthritis is rising, which makes regular and accurate medication administration necessary. Autoinjectors provide a practical and easy-to-use solution that enables patients to take their medications at home on their own. The need for autoinjectors is being driven by the rising incidence of chronic illnesses and the growing desire for individualised, patient-centred healthcare.

  • Technological Advancements

The continuous evolution of technology in the healthcare sector is a significant driver for the autoinjectors market. Technological advancements, such as the development of electronic autoinjectors and smart connected devices, have enhanced the precision, ease of use, and monitoring capabilities of these devices. Electronic autoinjectors, for instance, enable controlled and programmable drug delivery, ensuring accurate dosing and contributing to improved patient outcomes. As these innovations gain prominence, they not only address the need for efficient drug delivery but also cater to the growing trend of digital health solutions, creating a positive impact on the market's growth.

 

Restraints:

  • High Development Costs and Regulatory Challenges

The autoinjectors market faces challenges related to high development costs and stringent regulatory requirements. The development of innovative and technologically advanced autoinjectors demands substantial financial investments. Additionally, navigating complex regulatory pathways poses a barrier to entry for some market players, leading to a slower pace of product approvals and market entry. The financial and regulatory hurdles can impede the market's growth and limit the accessibility of advanced autoinjector technologies.

  • Patient Safety Concerns

Despite their widespread adoption, autoinjectors are not immune to concerns related to patient safety. Issues such as needlestick injuries, device malfunctions, or user errors can have serious consequences. These safety concerns may lead to hesitancy among patients and healthcare providers in fully embracing autoinjector solutions. Addressing and mitigating these safety challenges through rigorous testing, improved design, and user education are essential for sustaining the market's growth and fostering confidence in autoinjector use.

 

Opportunities:

  • Personalized Medicine and Biologics

The market for autoinjectors is poised for substantial growth due to the growing trend of personalised medicine and the expanding application of biologics in diverse therapeutic domains. When it comes to administering biologics, autoinjectors provide an excellent option for accurate and regulated dosing. The need for autoinjectors as the go-to drug delivery method is anticipated to rise as long as the pharmaceutical industry keeps concentrating on creating customised targeted therapies. This compatibility with the changing field of personalised medicine sets up the autoinjector market for long-term expansion and innovation.

 

Segment Overview

  • By therapy

In terms of therapy, the autoinjectors market encompasses various medical conditions and treatment areas. This includes anaphylaxis, which involves the rapid and severe allergic reactions requiring immediate intervention. Diabetes, another significant therapy segment, utilizes autoinjectors for the convenient and controlled administration of insulin. Autoinjectors are also employed in the treatment of Multiple Sclerosis, Rheumatoid Arthritis, and other therapies, providing patients with a user-friendly and efficient means of self-administering medications.

  • By End-users

End-users of autoinjectors include hospitals & clinics, home care settings, and ambulatory care settings. Hospitals and clinics often utilize autoinjectors for efficient and precise drug delivery in a clinical setting. Home care settings leverage the convenience of autoinjectors to empower patients with self-administration capabilities, fostering independence and adherence to treatment plans. Ambulatory care settings, including outpatient clinics and urgent care centers, may also utilize autoinjectors to streamline the administration process for various therapies.

  • By type

Autoinjectors are categorized by type into reusable and disposable autoinjectors. Reusable autoinjectors are designed for multiple administrations of the same medication, allowing patients to refill and reuse the device. Disposable autoinjectors, on the other hand, are designed for single-use, providing a convenient and hygienic solution for patients who require periodic injections.

 

Global Autoinjectors Overview by Region

With a strong healthcare system and a high incidence of chronic illnesses, including diabetes and autoimmune disorders, North America is a significant market. Europe is closely behind due to population ageing, rising healthcare costs, and technological advancements. The Asia-Pacific region is experiencing notable expansion as a result of growing patient populations with ailments like rheumatoid arthritis and diabetes, as well as improved self-administration awareness and an expanding healthcare infrastructure. In addition, a growing number of major market participants are forming alliances and working together in the Asia-Pacific market in an effort to capitalise on the potential of the region.

In Latin America and the Middle East, the autoinjectors market is influenced by improving healthcare access and a growing demand for efficient drug delivery methods. These regions exhibit a rising prevalence of chronic diseases, contributing to the increased adoption of autoinjectors. Africa, while currently representing a smaller share, is witnessing gradual market growth with increasing healthcare investments and a focus on improving treatment accessibility.

 

 

Global Autoinjectors market competitive landscape

Major players in the industry include AbbVie Inc., Eli Lilly and Company, Johnson & Johnson, Amgen Inc., and Biogen Inc. These companies consistently invest in research and development to enhance their product portfolios, introducing advanced autoinjector technologies and features to gain a competitive edge.

Partnerships and collaborations play a pivotal role in shaping the competitive dynamics of the market. Key players often engage in strategic alliances with pharmaceutical companies to develop and market autoinjectors tailored for specific therapeutic areas. This collaborative approach helps in leveraging the expertise of both parties, accelerating product development, and expanding market reach.

The market also witnesses a continuous influx of new entrants, particularly startups and biotechnology firms, aiming to introduce innovative autoinjector solutions. These entrants often focus on addressing unmet medical needs or improving user-friendliness to disrupt established market players. Additionally, mergers and acquisitions are prevalent strategies among industry leaders to expand their market presence, acquire complementary technologies, and enhance their overall competitiveness.

 

Global Autoinjectors Recent Developments

  • Oct 2023, Altaviz unveils a novel auto-injector platform designed for drug administration. AltaVISC is customizable to accommodate a diverse range of drug formulations.
  • Oct 2023, SHL Medical, a prominent provider of advanced drug delivery systems like autoinjectors and innovative specialty delivery systems, has forged a non-exclusive co-marketing partnership with Lifecore Biomedical (Nasdaq: LFCR). Lifecore is a fully integrated Contract Development and Manufacturing Organization (CDMO) with specialized expertise in developing, filling, and finishing complex sterile injectable pharmaceutical products in syringes and vials.

 

Scope of global Autoinjectors report

Global Autoinjectors report segmentation

ATTRIBUTE

DETAILS

By Route of Administration

  • Intramuscular
  • Subcutaneous

By Therapy

  • Anaphylaxis
  • Diabetes
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Other Therapies

By End-User

  • Hospitals & Clinics
  • Home Care Settings
  • Ambulatory Care Settings

By Type

  • Reusable Autoinjectors
  • Disposable Autoinjectors

By Geography

  • North America (USA, and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Russia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)

Customization Scope

  • Available upon request

Pricing

  • Available upon request

 

Objectives of the Study

The objectives of the study are summarized in 5 stages. They are as mentioned below:

  • Global Autoinjectors size and forecast: To identify and estimate the market size for global Autoinjectors market segmented by Route of Administration, Type, Therapy, End-User and by region. Also, to understand the consumption/ demand created by consumers between 2023 and 2031.
  • Market Landscape and Trends: To identify and infer the drivers, restraints, opportunities, and challenges for global Autoinjectors
  • Market Influencing Factors: To find out the factors which are affecting the market of global Autoinjectors among consumers.
  • Company Profiling:  To provide a detailed insight into the major companies operating in the market. The profiling will include the financial health of the company's past 2-3 years with segmental and regional revenue breakup, product offering, recent developments, SWOT analysis, and key strategies.

Research Methodology

Our research methodology has always been the key differentiating reason which sets us apart in comparison from the competing organizations in the industry. Our organization believes in consistency along with quality and establishing a new level with every new report we generate; our methods are acclaimed and the data/information inside the report is coveted. Our research methodology involves a combination of primary and secondary research methods. Data procurement is one of the most extensive stages in our research process. Our organization helps in assisting the clients to find the opportunities by examining the market across the globe coupled with providing economic statistics for each and every region.  The reports generated and published are based on primary & secondary research. In secondary research, we gather data for global Market through white papers, case studies, blogs, reference customers, news, articles, press releases, white papers, and research studies. We also have our paid data applications which includes hoovers, Bloomberg business week, Avention, and others.

Data Collection

Data collection is the process of gathering, measuring, and analyzing accurate and relevant data from a variety of sources to analyze market and forecast trends. Raw market data is obtained on a broad front. Data is continuously extracted and filtered to ensure only validated and authenticated sources are considered. Data is mined from a varied host of sources including secondary and primary sources.

Primary Research

After the secondary research process, we initiate the primary research phase in which we interact with companies operating within the market space. We interact with related industries to understand the factors that can drive or hamper a market. Exhaustive primary interviews are conducted. Various sources from both the supply and demand sides are interviewed to obtain qualitative and quantitative information for a report which includes suppliers, product providers, domain experts, CEOs, vice presidents, marketing & sales directors, Type & innovation directors, and related key executives from various key companies to ensure a holistic and unbiased picture of the market. 

Secondary Research

A secondary research process is conducted to identify and collect information useful for the extensive, technical, market-oriented, and comprehensive study of the market. Secondary sources include published market studies, competitive information, white papers, analyst reports, government agencies, industry and trade associations, media sources, chambers of commerce, newsletters, trade publications, magazines, Bloomberg BusinessWeek, Factiva, D&B, annual reports, company house documents, investor presentations, articles, journals, blogs, and SEC filings of companies, newspapers, and so on. We have assigned weights to these parameters and quantified their market impacts using the weighted average analysis to derive the expected market growth rate.

Top-Down Approach & Bottom-Up Approach

In the top – down approach, the Global Batteries for Solar Energy Storage Market was further divided into various segments on the basis of the percentage share of each segment. This approach helped in arriving at the market size of each segment globally. The segments market size was further broken down in the regional market size of each segment and sub-segments. The sub-segments were further broken down to country level market. The market size arrived using this approach was then crosschecked with the market size arrived by using bottom-up approach.

In the bottom-up approach, we arrived at the country market size by identifying the revenues and market shares of the key market players. The country market sizes then were added up to arrive at regional market size of the decorated apparel, which eventually added up to arrive at global market size.

This is one of the most reliable methods as the information is directly obtained from the key players in the market and is based on the primary interviews from the key opinion leaders associated with the firms considered in the research. Furthermore, the data obtained from the company sources and the primary respondents was validated through secondary sources including government publications and Bloomberg.

Market Analysis & size Estimation

Post the data mining stage, we gather our findings and analyze them, filtering out relevant insights. These are evaluated across research teams and industry experts. All this data is collected and evaluated by our analysts. The key players in the industry or markets are identified through extensive primary and secondary research. All percentage share splits, and breakdowns have been determined using secondary sources and verified through primary sources. The market size, in terms of value and volume, is determined through primary and secondary research processes, and forecasting models including the time series model, econometric model, judgmental forecasting model, the Delphi method, among Flywheel Energy Storage. Gathered information for market analysis, competitive landscape, growth trends, product development, and pricing trends is fed into the model and analyzed simultaneously.

Quality Checking & Final Review

The analysis done by the research team is further reviewed to check for the accuracy of the data provided to ensure the clients’ requirements. This approach provides essential checks and balances which facilitate the production of quality data. This Type of revision was done in two phases for the authenticity of the data and negligible errors in the report. After quality checking, the report is reviewed to look after the presentation, Type and to recheck if all the requirements of the clients were addressed.

Frequently Asked Questions

Global Autoinjectors forecast period is 2023 - 2031
According to global Autoinjectors research, the market is expected to grow at a CAGR of ~9.75% over the next eight years.
The possible segments in global Autoinjectors are based on by Route of Administration, Type, Therapy, End-User & by region.
The expected market size for Global Autoinjectors is USD 9.42 billion in 2022.
The major players in the market are Abbvie, Amgen, Teva Pharmaceuticals and Ypsomed.